Literature DB >> 11265585

HPLC enantiomeric resolution of nebivolol on normal and reversed amylose based chiral phases.

H Y Aboul-Enein1, I Ali.   

Abstract

Racemic nebivolol, a beta-adrenergic blocker showing very promising beta-adrenergic antagonist properties in comparison to other beta-adrenergic blockers has been resolved by HPLC under normal and reversed phase modes. The columns used were Chiralpak AD and Chiralpak AD-RH containing amylose tris (3,5-dimethyl phenyl carbamate) as the chiral selector. The mobile phases used were pure ethanol and 1-propanol. The flow rates used were 0.5, 1.0 and 1.5 ml/min. The best resolution was achieved at 0.5 ml/min. flow rate with ethanol and 1-propanol on both Chiralpak AD and Chiralpak AD-RH stationary phases. The values of infinity for both alcohols on Chiralpak AD were 1.38 while on Chiralpak AD-RH these values were 1.41 and 1.38 respectively. The values of Rs for ethanol and 1-propanol were 2.63 and 1.71 on Chiralpak AD and 1.73 and 1.76 on Chiralpak AD-RH respectively.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11265585

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Stability Indicating RP-HPLC Estimation of Nebivolol Hydrochloride in Pharmaceutical Formulations.

Authors:  D A Shah; K K Bhatt; R S Mehta; S L Baldania; T R Gandhi
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

2.  Eco-friendly UPLC-MS/MS analysis of possible add-on therapy for COVID-19 in human plasma: Insights of greenness assessment.

Authors:  Omnia A El-Naem; Sarah S Saleh
Journal:  Microchem J       Date:  2021-04-02       Impact factor: 4.821

3.  Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs.

Authors:  Imran Ali; Sofi Danish Mukhtar; Ming Fa Hsieh; Zeid A Alothman; Abdulrahman Alwarthan
Journal:  RSC Adv       Date:  2018-11-13       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.